Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016809
Chunk: 106

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 106
---
 13 or section 15(d) of the Securities Exchange 
 Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to   
 Rule 424(b) that is part of the registration statement.                                                                                   |

| (C) | Provided further, however, that paragraphs (1)(i) and (1)(ii) do not apply if the registration statement                               
 is for an offering of asset-backed securities on Form S-1 or Form S-3, and the information required to be included in a post-effective 
 amendment is provided pursuant to Item 1100(c) of Regulation.                                                                          |

| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective                                        
 amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities 
 at that time shall be deemed to be the initial bona fide offering thereof.                                                                   |

| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered 
 which remain unsold at the termination of the offering.                                                   |

| 55 |

| (4) | To file a post-effective amendment to the registration statement to include any financial statements required                              
 by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information   
 otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the prospectus, by means 
 of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure   
 that all other information in the prospectus is at least as current as the date of those financial statements.                             |

| (5) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |

| (i) | Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration 
 statement as of the date the filed prospectus was deemed part of and included in the registration statement; and  |

| (ii) | Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration                                  
 statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(